Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

You are here

Home » OPDYTA 40/100 mg (Nivolumab)
http://www.mbapharmaceuticals.com/product/nivolumab-opdyta/
Connect with this vendor - Learn about this product
Add to Favourite List
Request Info

OPDYTA 40/100 mg (Nivolumab)

MBA Pharmaceuticals Pvt Ltd
Category: 
Pharma & Supplements

Manufacturer : Bristol-Myers Squibb

Composition : Nivolumab 40/100 mg

Opdyta 100 mg Injection is used in the treatment of melanoma, non-small cell lung cancer, head and neck cancer, kidney cancer and non-Hodgkin lymphoma (NHL).

Ask for Quote : [email protected]

Specialty: 
Oncology
View this product at mbapharmaceuticals.com
We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy and Cookie Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
I Agree